Skip navigation
  • 中文
  • English

DSpace CRIS

  • DSpace logo
  • Home
  • Organizations
  • Researchers
  • Research Outputs
  • Explore by
    • Organizations
    • Researchers
    • Research Outputs
  • Academic & Publications
  • Sign in
  • 中文
  • English
  1. NTU Scholars
  2. 醫學院
  3. 醫學系
Please use this identifier to cite or link to this item: https://scholars.lib.ntu.edu.tw/handle/123456789/524202
Title: Riociguat improves pulmonary hemodynamics in patients with inoperable chronic thromboembolic pulmonary hypertension
Authors: CHENG-HSUAN TSAI 
CHO-KAI WU 
PING-HUNG KUO 
HSAO-HSUN HSU 
ZHENG-WEI CHEN 
HWANG, JUEY-JEN 
CHI-LUN KO 
YU-SEN HUANG 
YEN-HUNG LIN 
Issue Date: 2020
Publisher: Republic of China Society of Cardiology
Journal Volume: 36
Journal Issue: 1
Start page/Pages: 64-71
Source: Acta Cardiologica Sinica
Abstract: 
Background: Few studies have investigated the effects of riociguat on pulmonary hemodynamics in Asian patients with chronic thromboembolic pulmonary hypertension (CTEPH). In this study, we evaluated the effects of riociguat on pulmonary hemodynamics in inoperable CTEPH patients. Methods: We retrospectively collected the clinical data of 11 inoperable CTEPH patients. Pulmonary hemodynamic parameters of right heart catheterization, echocardiography, 6-minute walk distance and World Health Organization (WHO) functional class were assessed at baseline and after riociguat treatment. Results: The median duration of riociguat treatment was 12 months, and all 11 patients tolerated riociguat 7.5 mg/day well after titration. With regards to pulmonary hemodynamic data, both mean pulmonary artery pressure and pulmonary vascular resistance significantly decreased from 41 ? 8 mmHg to 38 ? 9 mmHg (p = 0.045) and 787 ? 417 dyn·s·cm-5 to 478 ? 267 dyn·s·cm-5 (p = 0.007), respectively. With regards to clinical symptoms, WHO functional class significantly improved in nine of the 11 patients, and there was no change in the other two patients (p = 0.004). In addition, the median level of N-terminal pro-brain natriuretic peptide also significantly decreased from 281 (117-5943) pg/ml to 226 (48-1276) pg/ml (p = 0.021). Conclusions: Riociguat treatment improved both clinical symptoms and pulmonary hemodynamics in the inoperative CTEPH patients in this study. ? 2020, Republic of China Society of Cardiology. All rights reserved.
URI: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077285001&doi=10.6515%2fACS.202001_36%281%29.20190612A&partnerID=40&md5=4601298c53f24a83f5a1bbc4d718c4da
https://scholars.lib.ntu.edu.tw/handle/123456789/524202
ISSN: 1011-6842
DOI: 10.6515/ACS.202001_36(1).20190612A
SDG/Keyword: alanine aminotransferase; amino terminal pro brain natriuretic peptide; aspartate aminotransferase; bilirubin; cholesterol; high density lipoprotein; low density lipoprotein; riociguat; triacylglycerol; anticoagulant therapy; antiphospholipid syndrome; Article; autoimmune hemolytic anemia; biochemical analysis; chronic thromboembolic pulmonary hypertension; clinical article; coronary artery disease; coronary vascular resistance; diabetes mellitus; echocardiography; end stage renal disease; endarterectomy; female; follow up; heart catheterization; heart left ventricle ejection fraction; heart left ventricle enddiastolic diameter; heart output; heart right atrium pressure; hospitalization; human; hypertension; lung angiography; lung artery pressure; lung embolism; lung hemodynamics; lung vascular resistance; lung wedge pressure; male; maximum tolerated dose; mortality; pulmonary artery occlusion pressure; retrospective study; six minute walk test; tricuspid valve regurgitation; venous thromboembolism
[SDGs]SDG3
Appears in Collections:醫學系

Show full item record

SCOPUSTM   
Citations

7
checked on Mar 6, 2023

WEB OF SCIENCETM
Citations

8
checked on Mar 19, 2023

Page view(s)

50
checked on Mar 20, 2023

Google ScholarTM

Check

Altmetric

Altmetric

Related Items in TAIR


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Sherpa Romeo網站查詢,以確認出版單位之版權政策。
    Please use Sherpa Romeo to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)
Build with DSpace-CRIS - Extension maintained and optimized by Logo 4SCIENCE Feedback